Hussman Strategic Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-51,500
Closed -$1.26M – 310
2020
Q3
$1.26M Hold
51,500
– – 0.33% 128
2020
Q2
$933K Buy
+51,500
New +$1.01M 0.24% 167
2019
Q3
– Sell
-50,000
Closed -$1.03M – 209
2019
Q2
$1.03M Sell
50,000
-27,800
-36% -$641K 0.29% 126
2019
Q1
$2.24M Sell
77,800
-800
-1% -$19.8K 0.55% 69
2018
Q4
$1.35M Buy
78,600
+3,600
+5% +$87.1K 0.33% 129
2018
Q3
$2.13M Buy
+75,000
New +$2.48M 0.62% 69

Other funds holding THC

Hussman Strategic Advisors's THC Position: Q4 2020 in Review

Hussman Strategic Advisors sold out of Tenet Healthcare (THC) in Q4 2020, closing a stake of 51,500 shares — an estimated $1.26M sold.

Hussman Strategic Advisors first reported a position in THC in Q3 2018 and held it in 6 quarters. The position peaked at $2.24M in Q1 2019. 278 funds tracked by Wall St. Rank hold THC as of Q4 2020.

  • Hussman Strategic Advisors reported no remaining Tenet Healthcare position as of Q4 2020 after selling out during the quarter.
  • Hussman Strategic Advisors sold 51,500 Tenet Healthcare shares in Q4 2020, an estimated $1.26M.
  • Hussman Strategic Advisors first reported a position in Tenet Healthcare in Q3 2018 and held it in 6 quarters.
  • Hussman Strategic Advisors's Tenet Healthcare position peaked at $2.24M in Q1 2019.
  • 278 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2020.

Based on Hussman Strategic Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.